Vitamin D Council needs your help...

Tax-deductible!

Together we can end the illness and disease caused by the worldwide epidemic of vitamin D deficiency.

About Vitamin D Council

Contact Vitamin D Council

Sponsor Vitamin D Council

Follow us on:

Vitamin D Products

(off-site)

These companies donate to the Vitamin D Council.

D-Lite, Renew, & SunSplash UV/Tanning Systems
In-Home ZRT Vitamin D Blood Test Kit
Get Premium Quality Vitamin D Supplements at Great Prices
Vitamin D3 Plus™ from Bio-Tech — contains the cofactors Vitamin D needs to work properly.

Vitamin D Research

back to research menu

Osteoporosis

Minimum Required Vitamin D Level for Optimal Increase in Bone Mineral Density with Alendronate Treatment in Osteoporotic Women. Calcif Tissue Int. 2009 Oct 1.
Evidence of association of Vitamin D receptor Apa I gene polymorphism with bone mineral density in postmenopausal women with osteoporosis. Clin Rheumatol. 2009 Oct;28(10):1187–91.
Management of osteoporosis in the elderly. Curr Med Res Opin. 2009 Oct;25(10):2373–87.
Metabolic osteopathy in celiac disease: importance of a gluten-free diet. Nutr Rev. 2009 Oct;67(10):599–606.
Osteoporosis and congestive heart failure (CHF) in the elderly patient: double disease burden. Arch Gerontol Geriatr. 2009 Sep–Oct;49(2):250–4.
Multiple sclerosis, osteoporosis, and vitamin D. J Neurol Sci. 2009 Sep 30.
Prevention of osteoporosis after breast cancer. Maturitas. 2009 Sep 20;64(1):4–8.
Risks of osteoporosis associated with breast cancer treatment: the need to access to preventive treatment. Maturitas. 2009 Sep 20;64(1):1–3.
Reducing fracture risk with calcium and vitamin D. Clin Endocrinol (Oxf). 2009 Sep 10.
Does vitamin D supplementation of healthy Danish Caucasian girls affect bone turnover and bone mineralization? Bone. 2009 Sep 6.
Vitamin D and calcium insufficiency-related chronic diseases: molecular and cellular pathophysiology. Eur J Clin Nutr. 2009 Sep 2.
Vitamin D metabolites as clinical markers in autoimmune and chronic disease. Ann N Y Acad Sci. 2009 Sep;1173:384–90.
Synthesis and biological activities of 14-epi-MART-10 and 14-epi-MART-11: implications for cancer and osteoporosis treatment. Anticancer Res. 2009 Sep;29(9):3563–9.
Long-term changes in bone mineral density and predicted fracture risk in patients receiving androgen-deprivation therapy for prostate cancer, with stratification of treatment based on presenting values. BJU Int. 2009 Sep;104(6):800–5.
Nutritional aspects of glucose metabolism and bone metabolism: knowledge of vitramins and minerales for NST activities. Clin Calcium. 2009 Sep;19(9):1339–44.
Clinical and therapeutic aspects of osteoporosis. Eur J Radiol. 2009 Sep;71(3):388–91.
Nutrition and health: guidelines for dental practitioners. Oral Dis. 2009 Sep;15(6):369–81.
Osteoporosis management among residents living in long-term care. Osteoporos Int. 2009 Sep;20(9):1471–8.
Update on cystic fibrosis-related bone disease: a special focus on children. Paediatr Respir Rev. 2009 Sep;10(3):134–42.
Management of osteoporosis in the elderly. Curr Med Res Opin. 2009 Aug 4.
Secondary Causes of Low Bone Mass in Patients With Breast Cancer: A Need for Greater Vigilance. J Clin Oncol. 2009 Aug 1;27(22):3605–10.
Prevalence and risk factors of low bone mineral density and 25-hydroxyvitamin D status in young healthy epileptic adult patients in a tropical Asian country taking antiepileptic drug. Bone. 2009 Aug;45(2):232–7.
Changes in 25-Hydroxyvitamin D3 to oral treatment with vitamin D3 in postmenopausal females with osteoporosis. Osteoporos Int. 2009 Aug;20(8):1329–35.
Undertreatment of osteoporosis following hip fracture in the elderly. Arch Gerontol Geriatr. 2009 Jul–Aug;49(1):153–7.
Changes of the quality-of-life under the treatment of severe senile osteoporosis with teriparatide. Arch Gerontol Geriatr. 2009 Jul–Aug;49(1):35–8.
Vitamin D Receptor Gene Polymorphisms Modulate The Skeletal Response to Vitamin D Supplementation in Healthy Girls. Bone. 2009 Jul 29.
Bone mineral density and disorders of mineral metabolism in chronic liver disease. World J Gastroenterol. 2009 Jul 28;15(28):3516–22.
Association between vitamin D receptor gene polymorphisms, falls, balance and muscle power: results from two independent studies (APOSS and OPUS). Osteoporos Int. 2009 Jul 24.
Search for hidden secondary causes in postmenopausal women with osteoporosis. Menopause. 2009 Jul 9.
Osteoporosis in inflammatory bowel disease. Am J Med. 2009 Jul;122(7):599–604. Review.
Hormones and Osteoporosis update. Vitamin D and Bone. Clin Calcium. 2009 Jul;19(7):920–8.
Blood biomarkers of osteoporosis in mild cognitive impairment and Alzheimer's disease. J Neural Transm. 2009 Jul;116(7):905–11.
Overcoming barriers to osteoporosis care in vulnerable elderly patients with hip fractures. J Orthop Trauma. 2009 Jul;23(6):454–9.
Response of calciotropic hormones and bone turnover to brisk walking according to age and fitness level. J Sci Med Sport. 2009 Jul;12(4):463–467.
Adverse effects of bisphosphonates: implications for osteoporosis management. Mayo Clin Proc. 2009 Jul;84(7):632–7; quiz 638.
Vitamin D insufficiency does not affect response of bone mineral density to alendronate. Osteoporos Int. 2009 Jul;20(7):1259–66.
Survey of spine surgeons on attitudes regarding osteoporosis and osteomalacia screening and treatment for fractures, fusion surgery, and pseudoarthrosis. Spine J. 2009 Jul;9(7):537–44.
Additional Beneficial Effects of Recombinant Growth Hormone in Alendronate-treated Patients with Idiopathic Osteoporosis. Endocr J. 2009 Jun 30.
Population screening for osteoporosis risk: a randomised control trial of medication use and fracture risk. Osteoporos Int. 2009 Jun 30.
Global vitamin D status and determinants of hypovitaminosis D. Osteoporos Int. 2009 Jun 19.
The role of cigarette smoking and statins in the development of postmenopausal osteoporosis: a pilot study utilizing the Marshfield Clinic Personalized Medicine Cohort. Osteoporos Int. 2009 Jun 9.
Vitamin D Binding Protein Genotype and Osteoporosis. Calcif Tissue Int. 2009 Jun 2.
Calcium Malabsorption Does Not Cause Secondary Hyperparathyroidism. Calcif Tissue Int. 2009 Jun 2.
Behavioural and physical characteristics associated with vitamin D status in women. Bone. 2009 Jun;44(6):1085–91.
Protective effect of total carotenoid and lycopene intake on the risk of hip fracture: a 17-year follow-up from the Framingham Osteoporosis Study. J Bone Miner Res. 2009 Jun;24(6):1086–94.
Vitamin K treatment reduces undercarboxylated osteocalcin but does not alter bone turnover, density, or geometry in healthy postmenopausal North American women. J Bone Miner Res. 2009 Jun;24(6):983–91.
Relationship between duration of teriparatide therapy and clinical outcomes in postmenopausal women with osteoporosis. Osteoporos Int. 2009 Jun;20(6):943–8.
Osteoporosis in Parkinson's disease. Parkinsonism Relat Disord. 2009 Jun;15(5):339–46.
Osteoporosis prevention in prostate cancer patients receiving androgen ablation therapy: placebo-controlled double-blind study of estradiol and risedronate: N01C8. Support Care Cancer. 2009 May 27.
Adherence to monthly and weekly oral bisphosphonates in women with osteoporosis. Osteoporos Int. 2009 May 21.
1-Alpha, 25-dihydroxy vitamin D(3) inhibits osteoclastogenesis through IFN-beta-dependent NFATc1 suppression. J Bone Miner Metab. 2009 May 19.
Differences in persistence, safety and efficacy of generic and original branded once weekly bisphosphonates in patients with postmenopausal osteoporosis: 1-year results of a retrospective patient chart review analysis. Rheumatol Int. 2009 May 9.
The importance of inflammation and vitamin D status in SLE-associated osteoporosis. Autoimmun Rev. 2009 May 7.
The Evaluation of Secondary Causes of Bone Loss in a Primary Care Setting. Endocr Pract. 2009 May 6:1–16.
Skeletal sequelae of cancer and cancer treatment. J Cancer Surviv. 2009 May 2.
Bone fracture and the healing mechanisms. Metabolic bone disease and skeletal healing. Clin Calcium. 2009 May;20(5):648–52.
Dietary calcium and serum 25-hydroxyvitamin D status in relation to BMD among U.S. adults. J Bone Miner Res. 2009 May;24(5):935–42.
Approach to the patient with transplantation-related bone loss. J Clin Endocrinol Metab. 2009 May;94(5):1483–90.
Is there any requirement for celiac disease screening routinely in postmenapausal women with osteoporosis? Rheumatol Int. 2009 May;29(7):841–5.
Osteoporosis and thyrotropin-suppressive therapy: reduced effectiveness of alendronate. Thyroid. 2009 May;19(5):437–42.
The aryl hydrocarbon receptor activator benzo[a]pyrene enhances vitamin D3 catabolism in macrophages. Toxicol Sci. 2009 May;109(1):50–8.
Comparison of the effects of 1,25 dihydroxyvitamin D and 25 hydroxyvitamin D on bone pathology and disease activity in Crohn's disease patients. Inflamm Bowel Dis. 2009 Apr 30.
Bone mineral density in estrogen deficient young women. J Clin Endocrinol Metab. 2009 Apr 28.
Prevalence and risk factors of low bone mineral density and 25-hydroxyvitamin D status in young healthy epileptic adult patients in a tropical Asian country taking antiepileptic drug. Bone. 2009 Apr 24.
Vitamin D and vitamin D analogues for preventing fractures associated with involutional and post-menopausal osteoporosis. Cochrane Database Syst Rev. 2009 Apr 15;(2):CD000227. Review.
The efficacy and tolerability of once-weekly alendronate 70 mg on bone mineral density and bone turnover markers in postmenopausal Chinese women with osteoporosis. J Bone Miner Metab. 2009 Apr 3.
Osteoporosis in Parkinson's disease. Parkinsonism Relat Disord. 2009 Apr 3.
Calcium-alkali syndrome due to vitamin D administration and magnesium oxide administration. Am J Kidney Dis. 2009 Apr;53(4):711–4.
Treatment of osteoporosis/osteopenia in pediatric leukemia and lymphoma. Ann Pharmacother. 2009 Apr;43(4):714–20.
Alendronate/vitamin D3 70 mg/2800 IU with and without additional 2800 IU vitamin D3 for osteoporosis: results from the 24-week extension of a 15-week randomized, controlled trial. Bone. 2009 Apr;44(4):639–47.
No difference between strontium ranelate (SR) and calcium/vitamin D on bone turnover markers in women with established osteoporosis previously treated with teriparatide: a randomized controlled trial. Clin Endocrinol (Oxf). 2009 Apr;70(4):522–6.
Serum leptin level in geriatric patients with hip fractures: possible correlation to biochemical parameters of bone remodeling. Arch Gerontol Geriatr. 2009 Mar–Apr;48(2):250–3.
Genetic and environmental factors in human osteoporosis from Sub-Saharan to Mediterranean areas. J Bone Miner Metab. 2009 Mar 3.
The combinations of polymorphisms in vitamin D receptor, osteoprotegerin and tumour necrosis factor superfamily member 11 genes are associated with bone mineral density. J Mol Endocrinol. 2009 Mar;42(3):239–47.
The efficacy and safety of calcitriol and/or Caltrate D in elderly Chinese women with low bone mass. Acta Pharmacol Sin. 2009 Mar;30(3):372–8.
Management of decreased bone mineral density in men starting androgen-deprivation therapy for prostate cancer. BJU Int. 2009 Mar;103(6):753–7.
Nutritional therapies (including fosteum). Curr Osteoporos Rep. 2009 Mar;7(1):5–11.
Age-related bone loss in the LOU/c rat model of healthy ageing. Exp Gerontol. 2009 Mar;44(3):183–9.
Pharmacotherapy guidelines for the aged by family doctors for the use of family doctors: Part C Special Pharmacology. Int J Clin Pharmacol Ther. 2009 Mar;Volume 47(March):141–152.
Effects of platelet-derived growth factor, vitamin D and parathyroid hormone on osteoblasts derived from cancer patients on chronic bisphosphonate therapy. Int J Mol Med. 2009 Mar;23(3):407–13.
A double-blinded, randomized controlled trial of zoledronate therapy for HIV-associated osteopenia and osteoporosis. AIDS. 2009 Jan 2;23(1):51–7.
Contributions of 25-hydroxyvitamin D, co-morbidities and bone mass to mortality in Japanese postmenopausal women. Bone. 2009 Jan;44(1):168–72.
RANKL/OPG in primary cultures of osteoblasts from post-menopausal women. Differences between osteoporotic hip fractures and osteoarthritis. J Steroid Biochem Mol Biol. 2009 Jan;113(1–2):46–51.
Vitamin D: skeletal and extra skeletal effects; recommendations for good practice. Presse Med. 2009 Jan;38(1):43–54. Review.
Improving detection and treatment of osteoporosis: redesigning care using the electronic medical record and shared medical appointments. Osteoporos Int. 2009 Jan;20(1):37–42.
Bone Mineral Density and Vitamin D Status in Female and Male Patients with Osteoarthritis of the Knee or Hip. Eur Surg Res. 2009;42(1):1–10.
Correlation between bone markers and bone mineral density in postmenopausal women with osteoporosis. Endocr Pract. 2008 Dec;14(9):1102–7.
Effect of Roux-en Y Gastric Bypass on Bone Metabolism in Patients with Morbid Obesity: Mansoura Experiences. Obes Surg. 2008 Dec;18(12):1526–31.
Closing the Gap: Bone Health Education in Orthopaedic Practice. Orthop Nurs. 2008 Nov–Dec;27(6):340–6; quiz 347–8.
Prevalence of Secondary Causes of Bone Loss Among Breast Cancer Patients With Osteopenia and Osteoporosis. J Clin Oncol. 2008 Nov 20;26(33):5380–5.
High bone turnover but normal bone mineral density in women suffering from schizophrenia. Psychol Med. 2008 Aug;38(8):1195–201.
Risk factors of musculoskeletal ambulation disability symptom complex (MADS). - Frequent falls and sarcopenia according to aging -. Clin Calcium. 2008 Nov;18(11):1581–7. In Japanese.
Daily oral 25-hydroxycholecalciferol supplementation for vitamin D deficiency in haemodialysis patients: effects on mineral metabolism and bone markers. Nephrol Dial Transplant. 2008 Nov;23(11):3670–6.
Inadequate responders to osteoporosis treatment: proposal for an operational definition. Osteoporos Int. 2008 Nov;19(11):1511–6.
Adequate level of vitamin D is essential for maintaining good health. Postepy Hig Med Dosw (Online). 2008 Oct 9;62:502–10. In Polish.
Screening for osteoporosis: a survey of older psychiatric inpatients at a tertiary referral centre. Int Psychogeriatr. 2008 Oct 6:1–7.
Vitamin D: a rapid review. Urol Nurs. 2008 Oct;28(5):343–9, 384; quiz 350.
A sheep model for fracture treatment in osteoporosis: benefits of the model versus animal welfare. Lab Anim. 2008 Oct;42(4):453–64.
Guidelines for the management of osteoporosis. Internist (Berl). 2008 Oct;49(10):1178, 1180–2, 1184–5. In German.
The Decline in Hip Bone Density Following Gastric Bypass Surgery is Associated with Extent of Weight Loss. J Clin Endocrinol Metab. 2008 Oct;93(10):3735–40.
Update on vitamin D and evaluation of vitamin D status. Ann Endocrinol (Paris). 2008 Sep 17. In French.
Skeletal effects of systemic and topical corticosteroids. Curr Drug Saf. 2008 Sep;3(3):190–3. Review.
Osteoporotic Caucasian and South Asian women: a qualitative study of general practitioners' support. J R Soc Health. 2008 Sep;128(5):263–70.
Hypovitaminosis D among rheumatology outpatients in clinical practice. Rheumatology (Oxford). 2008 Sep;47(9):1348–51.
Novel vitamin D3 analogs, 1alpha, 25(OH)2D(3)-26, 23-lactam (DLAMs), antagonize bone resorption via suppressing RANKL expression in osteoblasts. Biochem Biophys Res Commun. 2008 Aug 1;372(3):434–9.
African Americans, 25-hydroxyvitamin D, and osteoporosis: a paradox. Am J Clin Nutr. 2008 Aug;88(2):545S–550S. Review.
Practical guidance for the management of aromatase inhibitor-associated bone loss. Ann Oncol. 2008 Aug;19(8):1407–16.
Osteoporosis in developing countries. Best Pract Res Clin Rheumatol. 2008 Aug;22(4):693–708.
Vitamin D receptor activators can protect against vascular calcification. J Am Soc Nephrol. 2008 Aug;19(8):1509–19.
Primary and secondary prophylaxis to the use of inhaled glucocorticoid in primary health care. J Asthma. 2008 Aug;45(6):519–22.
Calcium requirements of growing rats based on bone mass, structure, or biomechanical strength are similar. J Nutr. 2008 Aug;138(8):1462–8.
The recognition and treatment of vertebral fractures in males with chronic obstructive pulmonary disease. Respir Med. 2008 Aug;102(8):1165–72.
Alzheimer's disease and osteoporosis: common risk factors or one condition predisposing to the other? Ortop Traumatol Rehabil. 2008 Jul–Aug;10(4):309–17.
Salmon calcitonin in prevention of osteoporosis in maintenance dialysis patients. Chin Med J (Engl). 2008 Jul 20;121(14):1280–4.
Predictors of bone density in ambulatory patients on antiepileptic drugs. Bone. 2008 Jul;43(1):149–55.
Hypovitaminosis D in chronic kidney disease. Clin J Am Soc Nephrol. 2008 Jul;3(4):1144–51.
Protein-containing nutrient supplementation following strength training enhances the effect on muscle mass, strength, and bone formation in postmenopausal women. J Appl Physiol. 2008 Jul;105(1):274–81.
The remodeling transient and the calcium economy. Osteoporos Int. 2008 Jul;19(7):1001–9.
Molecular aspects of osteopathy in type 1 Gaucher disease: correlation between genetics and bone density. Rheumatol Int. 2008 Jul;28(9):873–7.
Effect on bone density of postoperative calcium and vitamin-D supplementation in patients with primary hyperparathyroidism: A retrospective study. Langenbecks Arch Surg. 2008 Jun 11.
3-year follow-up of 215 fracture patients from a prospective and consecutive osteoporosis screening program. Fracture patients care! Acta Orthop. 2008 Jun;79(3):404–9.
Vitamin D status and bone density in recently diagnosed inflammatory bowel disease: the Manitoba IBD Cohort Study. Am J Gastroenterol. 2008 Jun;103(6):1451–9.
Vitamin D deficiency and low bone status in adult female garment factory workers in Bangladesh. Br J Nutr. 2008 Jun;99(6):1322–9.
Osteoporotic fractures: a brain or bone disease? Curr Osteoporos Rep. 2008 Jun;6(2):57–61.
Osteoporosis among patients with type 1 and type 2 diabetes. Diabetes Metab. 2008 Jun;34(3):193–205. Review.
Osteoporosis in men. Endocr Rev. 2008 Jun;29(4):441–64. Review.
Prevention, diagnosis, and treatment of glucocorticoid induced osteoporosis by rheumatologists in a Latin-American city. J Clin Rheumatol. 2008 Jun;14(3):153–5.
Prevention and treatment of postmenopausal osteoporosis. Obstet Gynecol Clin North Am. 2008 Jun;35(2):301–15, ix. Review.
Secondary osteoporosis in long-term bedridden patients with cerebral palsy. Pediatr Int. 2008 Jun;50(3):269–75.
Fracture risk and bone mineral density in Turner syndrome. Rev Endocr Metab Disord. 2008 Jun;9(2):145–51. Review.
Studies on the mechanisms of the skeletal anabolic action of endogenous and exogenous parathyroid hormone. Arch Biochem Biophys. 2008 May 15;473(2):218–24. Review.
Influence of adjuvant pain medication on quality of life in the treatment of postmenopausal osteoporosis. Orthopade. 2008 May;37(5):435–9. In German.
Insulin resistance, renal injury, renal 1-alpha hydroxylase, and bone homeostasis in aged obese rats. Arch Med Res. 2008 May;39(4):380–7.
Vitamin D status in postmenopausal women living at higher latitudes in the UK in relation to bone health, overweight, sunlight exposure and dietary vitamin D. Bone. 2008 May;42(5):996–1003.
New insights into the role of vitamin D and calcium in osteoporosis management: an expert roundtable discussion. Curr Med Res Opin. 2008 May;24(5):1363–70. Review.
Osteoporosis and its implications for dental patients. J Am Dent Assoc. 2008 May;139(5):545–52; quiz 625–6. Review.
OPG and sRANKL serum concentrations in osteopenic, postmenopausal women after 2-year genistein administration. J Bone Miner Res. 2008 May;23(5):715–20.
Effects of raloxifene therapy on circulating osteoprotegerin and RANK ligand levels in post-menopausal osteoporosis. J Endocrinol Invest. 2008 May;31(5):416–21.
Generalized metabolic bone disease in Neurofibromatosis type I. Mol Genet Metab. 2008 May;94(1):105–11.
Calcium and vitamin D intake influence bone mass, but not short-term fracture risk, in Caucasian postmenopausal women from the National Osteoporosis Risk Assessment (NORA) study. Osteoporos Int. 2008 May;19(5):673–9.
Sickle cell bone disease: response to vitamin D and calcium. Am J Hematol. 2008 Apr;83(4):271–4.
Prevalence & potential significance of vitamin D deficiency in Asian Indians. Indian J Med Res. 2008 Mar;127(3):229–38. Review.
Systematic review: comparative effectiveness of treatments to prevent fractures in men and women with low bone density or osteoporosis. Ann Intern Med. 2008 Feb 5;148(3):197–213.
Vitamin D supplementation has minor effects on parathyroid hormone and bone turnover markers in vitamin D-deficient bedridden older patients. Age Ageing. 2008 Jan;37(1):25–31.
Evaluation of bone mineral density in cystic fibrosis patients. Rev Port Pneumol. 2008 Set/Out;14(5):625–634.
Association analysis of vitamin D receptor gene polymorphisms with bone mineral density in young women with Graves' disease. Acta Biochim Pol. 2008;55(2):371–80.
Vitamin D insufficiency/deficiency in gastrointestinal disorders. J Bone Miner Res. 2007 Dec;22 Suppl 2:V50–4. Review.
Vitamin D: molecular mechanism of action. Ann N Y Acad Sci. 2007 Nov;1116:340–8. Review.
Vitamin D and its implications for musculoskeletal health in women: An update. Maturitas. 2007 Oct 20;58(2):117–37. Review.
Vitamin D and muscle strength in patients with previous fractures. N Z Med J. 2007 Sep 21;120(1262):U2730.
Correlation of plain radiographic indices of the hip with quantitative bone mineral density. Osteoporos Int. 2007 Aug;18(8):1119–26.
Prevention and treatment of osteoporosis in short stay departments of nursing homes: a nursing home physician's task Tijdschr Gerontol Geriatr. 2007 Jul;38(3):147–53.
Bone mineral density and bone markers in patients with a recent low-energy fracture: effect of 1 y of treatment with calcium and vitamin D. Am J Clin Nutr. 2007 Jul;86(1):251–9.
What is new in vitamin D: 2006–2007. Curr Opin Rheumatol. 2007 Jul;19(4):383–8.
Vitamin d and rehabilitation: improving functional outcomes. Nutr Clin Pract. 2007 Jun;22(3):297–304. Review.
Vitamin D status predicts physical performance and its decline in older persons. J Clin Endocrinol Metab. 2007 Jun;92(6):2058–65.
Experimental osteoporosis induced by ovariectomy and vitamin D deficiency does not markedly affect fracture healing in rats. Acta Orthop. 2007 Jun;78(3):393–403.
The incidence of osteopenia and osteoporosis in women with hip osteoarthritis scheduled for cementless total joint replacement. Bone. 2007 Apr;40(4):1041–7.
Prevalence and predictors of osteoporosis treatment in nursing home residents with known osteoporosis or recent fracture. Osteoporos Int. 2007 Apr;18(4):553–9.
Associations of vitamin D status with bone mineral density, bone turnover, bone loss and fracture risk in healthy postmenopausal women. The OFELY study. Bone. 2007 Mar;40(3):716–22.
Medical management of patients over 50 years admitted to orthopedic surgery for low-energy fracture. Joint Bone Spine. 2007 Mar;74(2):160–5.
Superiority of a combined treatment of Alendronate and Alfacalcidol compared to the combination of Alendronate and plain vitamin D or Alfacalcidol alone in established postmenopausal or male osteoporosis (AAC-Trial). Rheumatol Int. 2007 Mar;27(5):425–34.
Structure-activity relationships of 19-norvitamin D analogs having a fluoroethylidene group at the C-2 position. Bioorg Med Chem. 2007 Feb 1;15(3):1475–82.
Vitamin D and vascular calcification. Curr Opin Lipidol. 2007 Feb;18(1):41–6. Review.
New 19-nor-(20S)-1alpha,25-dihydroxyvitamin D(3) analogs strongly stimulate osteoclast formation both in vivo and in vitro. Bone. 2007 Feb;40(2):293–304.
ED-71, a novel vitamin D analog, promotes bone formation and angiogenesis and inhibits bone resorption after bone marrow ablation. Bone. 2007 Feb;40(2):281–292.
Osteoporosis treatment. Rev Med Suisse. 2007 Jan 17;3 (94):150–3. In French.
Favourable and unfavourable effects of exposure to sunlight. Ned Tijdschr Geneeskd. 2007 Jan 13;151(2):118–22. Review In Dutch.
Strontium ranelate reduces the urinary level of cartilage degradation biomarker CTX-II in postmenopausal women. Bone. 2007 Jan;40(1):218–22.
Optimal vitamin D status for the prevention and treatment of osteoporosis. Drugs Aging. 2007;24(12):1017–29. Review.
Relationships between Myocardial Injury, All-cause Mortality, Vitamin D, PTH, and Biochemical Bone Turnover Markers in Older Patients with Hip Fractures. Annals of Clinical and Laboratory Science 37:222–232 (2007).
Long-term effects of calcium-vitamin-D3-fortified milk on bone geometry and strength in older men. Bone. 2006 Oct;39(4):946–53.
Renal tubular acidosis type 2 with Fanconi's syndrome, osteomalacia, osteoporosis, and secondary hyperaldosteronism in an adult consequent to vitamin D and calcium deficiency: effect of vitamin D and calcium citrate therapy. Endocr Pract. 2006 Sep–Oct;12(5):559–67.
The role of vitamin D for bone health and fracture prevention. Curr Osteoporos Rep. 2006 Sep;4(3):96–102. Review.
Vitamin D physiology. Prog Biophys Mol Biol. 2006 Sep;92(1):4–8. Review.
Optimal vitamin D status and serum parathyroid hormone concentrations in African American women. Am J Clin Nutr. 2006 Sep;84(3):602–9.
Vitamin D receptor gene polymorphism in rheumatoid arthritis and associated osteoporosis. Rheumatol Int. 2006 Sep;26(11):964–71.
The Association between Common Vitamin D Receptor Gene Variations and Osteoporosis: A Participant-Level Meta-Analysis. 15 August 2006 | Volume 145 Issue 4 | Pages 255–264.
Risk factors for vitamin D inadequacy among women with osteoporosis: an international epidemiological study. International Journal of Clinical Practice Volume 60 Issue 8 Page 1013—August 2006.
Vitamin D deficiency: A global perspective. Arq Bras Endocrinol Metabol. 2006 Aug;50(4):640–6.
Alendronate and vitamin D2 for prevention of hip fracture in Parkinson's disease: a randomized controlled trial. Mov Disord. 2006 Jul;21(7):924–9.
Osteoporotic fractures and vitamin D deficiency. Aust Fam Physician. 2006 Jul;35(7):519–20, 522.
A positive dose-response effect of vitamin D supplementation on site-specific bone mineral augmentation in adolescent girls: a double-blinded randomized placebo-controlled 1-year intervention. J Bone Miner Res. 2006 Jun;21(6):836–44.
Bone resorption markers in vitamin D insufficiency. Clin Chim Acta. 2006 Jun;368(1–2):48–52.
Effect of vitamin D supplementation on vitamin D status and bone turnover markers in young adults. Eur J Clin Nutr. 2006 Jun;60(6):727–33.
Addressing the musculoskeletal components of fracture risk with calcium and vitamin D: a review of the evidence. Calcif Tissue Int. 2006 May;78(5):257–70. Review.
Vitamin D2 dose required to rapidly increase 25OHD levels in osteoporotic women. Eur J Clin Nutr. 2006 May;60(5):681–7.
Vitamin D and African Americans. J Nutr. 2006 Apr;136(4):1126–9.
Preventing osteoporosis-related fractures: an overview. Am J Med. 2006 Apr;119(4 Suppl 1):S3–S11. Review.
Vitamin D status of 51–75-year-old Irish women: its determinants and impact on biochemical indices of bone turnover. Public Health Nutr. 2006 Apr;9(2):225–33.
Calcium- and vitamin D3-fortified milk reduces bone loss at clinically relevant skeletal sites in older men: a 2-year randomized controlled trial. J Bone Miner Res. 2006 Mar;21(3):397–405.
Superiority of alfacalcidol compared to vitamin D plus calcium in lumbar bone mineral density in postmenopausal osteoporosis. Rheumatol Int. 2006 Mar;26(5):445–53.
Assessment of vitamin D status in male osteoporosis. Clin Chem. 2006 Feb;52(2):248–54.
Calcium plus vitamin D supplementation and the risk of fractures. N Engl J Med. 2006 Feb 16;354(7):669–83.
Osteoblast dysfunction in male idiopathic osteoporosis. Calcif Tissue Int. 2006 Feb;78(2):90–7.
Responsiveness to phytoestrogens in primary human osteoblasts is modulated differentially by a "less-calcemic" analog of 1,25 dihydroxyvitamin D(3): JK 1624F(2)-2 (JKF). J Steroid Biochem Mol Biol. 2006 Feb;98(2–3):139–46.
Recent advances in the genetics of osteoporosis. J Musculoskelet Neuronal Interact. 2006 Jan–Mar;6(1):27–35. Review.
Prevalence of vitamin D inadequacy in Belfast following fragility fracture. Curr Med Res Opin. 2006 Jan;22(1):101–5.
Calcium, vitamin D and involutional osteoporosis. Curr Opin Clin Nutr Metab Care. 2006 Jan;9(1):13–7. Review.
Genetic Ablation of Vitamin D Activation Pathway Reverses Biochemical and Skeletal Anomalies in Fgf-23-Null Animals. American Journal of Pathology. 2006;169:2161–2170.
The Inpatient Consultation Approach to Osteoporosis Treatment in Patients with a Fracture. The Journal of Bone and Joint Surgery (American). 2006;88:1968–1974.
Vitamin D and intact PTH status in patients with hip fracture. Osteoporos Int. 2006;17(11):1608–14.
Determinants of vitamin D status in older women living in a subtropical climate. Osteoporos Int. 2005 Dec;16(12):1641–8.
Influence of ultraviolet radiation on the production of 25 hydroxyvitamin D in the elderly population in the city of Sao Paulo (23 degrees 34'S), Brazil. Osteoporos Int. 2005 Dec;16(12):1649–54.
Vitamin D, parathyroid hormone levels and bone mineral density in community-dwelling older women: the Rancho Bernardo Study. Osteoporos Int. 2005 Dec;16(12):1721–6.
Vitamin D: important for prevention of osteoporosis, cardiovascular heart disease, type 1 diabetes, autoimmune diseases, and some cancers. South Med J. 2005 Oct;98(10):1024–7. Review.
25-hydroxyvitamin D levels and bone histomorphometry in hemodialysis renal osteodystrophy. Kidney Int. 2005 Oct;68(4):1840–8.
Vitamin D inadequacy among post-menopausal women: a systematic review. QJM. 2005 Sep;98(9):667–76. Review.
Alfacalcidol versus plain vitamin D in the treatment of glucocorticoid/inflammation-induced osteoporosis. J Rheumatol Suppl. 2005 Sep;76:33–40.
Alfacalcidol versus plain vitamin D in inflammation induced bone loss. J Rheumatol Suppl. 2005 Sep;76:26–32. Review.
The therapeutic effects of alfacalcidol on bone strength, muscle metabolism and prevention of falls and fractures. J Musculoskelet Neuronal Interact. 2005 Jul–Sep;5(3):273–84. Review.
Amelioration of osteoporosis and hypovitaminosis D by sunlight exposure in hospitalized, elderly women with Alzheimer's disease: a randomized controlled trial. J Bone Miner Res. 2005 Aug;20(8):1327–33.
The prevention of hip fracture with risedronate and ergocalciferol plus calcium supplementation in elderly women with Alzheimer disease: a randomized controlled trial. Arch Intern Med. 2005 Aug 8–22;165(15):1737–42.
A randomized controlled trial of vitamin D3 supplementation in African American women. Arch Intern Med. 2005 Jul 25;165(14):1618–23.
Vitamin D and vitamin D analogues for preventing fractures associated with involutional and post-menopausal osteoporosis. Cochrane Database Syst Rev. 2005 Jul 20;(3):CD000227. Review.
Benefits and requirements of vitamin D for optimal health: a review. Altern Med Rev. 2005 Jun;10(2):94–111. Review.
Effect of intermittent administration of 200 IU intranasal salmon calcitonin and low doses of 1alpha(OH) vitamin D3 on bone mineral density of the lumbar spine and hip region and biochemical bone markers in women with postmenopausal osteoporosis: a pilot study. Clin Rheumatol. 2005 Jun;24(3):232–8.
Prevalence of Vitamin D inadequacy among postmenopausal North American women receiving osteoporosis therapy. J Clin Endocrinol Metab. 2005 Jun;90(6):3215–24.
Fracture prevention with vitamin D supplementation: a meta-analysis of randomized controlled trials. JAMA. 2005 May 11;293(18):2257–64. Review.
Seasonality of vitamin D status and bone turnover in patients with Crohn's disease. Aliment Pharmacol Ther. 2005 May 1;21(9):1073–83.
Vitamin D and calcium deficits predispose for multiple chronic diseases. Eur J Clin Invest. 2005 May;35(5):290–304. Review.
Randomised controlled trial of calcium and supplementation with cholecalciferol (vitamin D3) for prevention of fractures in primary care. BMJ 2005;330:1003 (30 April)
Vitamin-D receptor (VDR) gene (Fok-I, Taq-I and Apa-I) polymorphisms in healthy individuals from north Indian population. Asian Pac J Cancer Prev. 2005 Apr–Jun;6(2):147–52.
Prevalence of vitamin D insufficiency in postmenopausal south Indian women. Osteoporos Int. 2005 Apr;16(4):397–402.
Vitamin D and the elderly. Clin Endocrinol (Oxf). 2005 Mar;62(3):265–81. Review.
Vitamin D analogs versus native vitamin D in preventing bone loss and osteoporosis-related fractures: a comparative meta-analysis. Calcif Tissue Int. 2005 Mar;76(3):176–86.
Menatetrenone and vitamin D2 with calcium supplements prevent nonvertebral fracture in elderly women with Alzheimer's disease. Bone. 2005 Jan;36(1):61–8.
The role of vitamin D in the prevention of osteoporosis. Ann Med. 2005;37(4):278–85. Review.
Tanning is associated with optimal vitamin D status (serum 25-hydroxyvitamin D concentration) and higher bone mineral density. Am J Clin Nutr. 2004 Dec;80(6):1645–9.
Sunlight and vitamin D for bone health and prevention of autoimmune diseases, cancers, and cardiovascular disease. Am J Clin Nutr. 2004 Dec;80(6 Suppl):1678S–88S. Review.
Effect of supplementation of calcium and vitamin D on bone mineral density and bone mineral content in peri- and post-menopause women; a double-blind, randomized, controlled trial. Pharmacol Res. 2004 Dec;50(6):637–41.
Osteoarthritis and osteoporosis in postmenopausal women: clinical similarities and differences. Menopause. 2004 Nov–Dec;11(6 Pt 1):615–21. Review.
Effects of usual nutrient intake and vitamin D status on markers of bone turnover in Swiss adolescents. Eur J Clin Nutr. 2004 Sep;58(9):1257–65.
Supplementation with oral vitamin D3 and calcium during winter prevents seasonal bone loss: a randomized controlled open-label prospective trial. J Bone Miner Res. 2004 Aug;19(8):1221–30.
The relationship between vitamin D and parathyroid hormone: calcium homeostasis, bone turnover, and bone mineral density in postmenopausal women with established osteoporosis. Bone. 2004 Jul;35(1):312–9.
Prevalence and seasonal variation of hypovitaminosis D and its relationship to bone metabolism in community dwelling postmenopausal Hungarian women. Osteoporos Int. 2004 Jun;15(6):447–51.
Which circulating level of 25-hydroxyvitamin D is appropriate? J Steroid Biochem Mol Biol. 2004 May;89–90(1–5):611–4. Review.
Vitamin D: importance in the prevention of cancers, type 1 diabetes, heart disease, and osteoporosis. Am J Clin Nutr. 2004 Mar;79(3):362–71. Review.
Vitamin D and calcium supplementation prevents osteoporotic fractures in elderly community dwelling residents: a pragmatic population-based 3-year intervention study. J Bone Miner Res. 2004 Mar;19(3):370–8.
A randomised, controlled comparison of different calcium and vitamin D supplementation regimens in elderly women after hip fracture: The Nottingham Neck of Femur (NONOF) Study. Age Ageing. 2004 Jan;33(1):45–51.
Tanning is associated with optimal vitamin D status (serum 25-hydroxyvitamin D concentration) and higher bone mineral density. Am J Clin Nutr 2004;80:1645–9.
Bone density, parathyroid hormone, calcium and vitamin D nutritional status of institutionalized elderly subjects. J Nutr Health Aging. 2004;8(5):400–4.
Role of vitamin D and parathyroid hormone in the regulation of bone turnover and bone mass in men: the Minos study. Calcif Tissue Int. 2003 Dec;73(6):520–30.
Effect of vitamin D on muscle strength and relevance in regard to osteoporosis prevention. Z Rheumatol. 2003 Dec;62(6):518–21. In German.
Vitamin D and bone health in early life. Proc Nutr Soc. 2003 Nov;62(4):823–8. Review.
Prediction of bone mass density variation by bone remodeling markers in postmenopausal women with vitamin D insufficiency treated with calcium and vitamin D supplementation. J Clin Endocrinol Metab. 2003 Nov;88(11):5175–9.
Association of low 25-hydroxyvitamin D concentrations with elevated parathyroid hormone concentrations and low cortical bone density in early pubertal and prepubertal Finnish girls. Am J Clin Nutr. 2003 Sep;78(3):485–92.
Effect of gender, puberty, and vitamin D status on biochemical markers of bone remodedeling. Bone. 2003 Aug;33(2):242–7.
Amelioration of osteoporosis and hypovitaminosis D by sunlight exposure in stroke patients. Neurology. 2003 Aug 12;61(3):338–42.
Pins and plaster aren't enough: a call for the evaluation and treatment of patients with osteoporotic fractures. J Clin Endocrinol Metab. 2003 Aug;88(8):3482–6. Review.
Effects on bone mineral density of calcium and vitamin D supplementation in elderly women with vitamin D deficiency. Joint Bone Spine. 2003 Jun;70(3):203–8.
Vitamin D status and measurements of markers of bone metabolism in patients with small intestinal resection. Gut. 2003 May;52(5):653–8.
Vitamin D and bone health in postmenopausal women. J Womens Health (Larchmt). 2003 Mar;12(2):151–6. Review.
Effect of four monthly oral vitamin D3 (cholecalciferol) supplementation on fractures and mortality in men and women living in the community: randomised double blind controlled trial. BMJ 2003;326:469 (1 March)
Calcium and vitamin D. Endocrinol Metab Clin North Am. 2003 Mar;32(1):181–94, vii–viii. Review.
Calcium, vitamin D, milk consumption, and hip fractures: a prospective study among postmenopausal women. Am J Clin Nutr. 2003 Feb;77(2):504–11.
Rationale for active vitamin D and analogs in the treatment of osteoporosis. J Cell Biochem. 2003 Feb 1;88(2):381–6. Review.
Vitamin D and attainment of peak bone mass among peripubertal Finnish girls: a 3-y prospective study. Am J Clin Nutr. 2002 Dec;76(6):1446–53.
Relationship between serum 25-hydroxyvitamin D and bone resorption markers in vitamin D insufficiency. Bone. 2002 Nov;31(5):626–30.
2002 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada. CMAJ. 2002 Nov 12;167(10 Suppl):S1–34. Review.
Deletion of deoxyribonucleic acid binding domain of the vitamin D receptor abrogates genomic and nongenomic functions of vitamin D. Mol Endocrinol. 2002 Jul;16(7):1524–37.
Vitamin K deficiency and osteopenia in vitamin D-deficient elderly women with Parkinson's disease. Arch Phys Med Rehabil. 2002 Jan;83(1):86–91.
Role of Ca(2+) and vitamin D in the prevention and treatment of osteoporosis. Pharmacol Ther. 2002 Jan;93(1):37–49. Review.
Vitamin D deficiency and aging: implications for general health and osteoporosis. Biogerontology. 2002;3(1–2):73–7.
A cross-sectional study on biochemical parameters of bone turnover and vitamin d metabolites in healthy dutch children and young adults. Horm Res. 2002;57(5–6):170–9.
Longitudinal evaluation of vitamin D status in healthy subjects from southern Italy: seasonal and gender differences. Osteoporos Int. 2001 Dec;12(12):1026–30.
Seasonal variations in serum levels of 25-hydroxyvitamin D and parathyroid hormone but no detectable change in femoral neck bone density in an older population with regular outdoor exposure. J Am Geriatr Soc. 2001 Sep;49(9):1190–6.
Vitamin D deficiency and secondary hyperparathyroidism in the elderly: consequences for bone loss and fractures and therapeutic implications. Endocr Rev. 2001 Aug;22(4):477–501. Review.
Vitamin D status affects serum parathyroid hormone concentrations during winter in female adolescents: associations with forearm bone mineral density. Am J Clin Nutr. 2001 Aug;74(2):206–10.
Vitamin D deficiency and risk of hip fractures among disabled elderly stroke patients. Stroke. 2001 Jul;32(7):1673–7.
Vitamin D nutrition and bone disease in adults. Rev Endocr Metab Disord. 2001 Apr;2(2):153–64. Review.
Calcium and vitamin D nutrition and bone disease of the elderly. Public Health Nutr. 2001 Apr;4(2B):547–59. Review.
A global study of vitamin D status and parathyroid function in postmenopausal women with osteoporosis: baseline data from the multiple outcomes of raloxifene evaluation clinical trial. J Clin Endocrinol Metab. 2001 Mar;86(3):1212–21.
Vitamin D and vitamin D analogues for preventing fractures associated with involutional and post-menopausal osteoporosis. Cochrane Database Syst Rev. 2001;(1):CD000227. Review.
Vitamin D and bone mineral density in ambulatory women living in Buenos Aires, Argentina. Osteoporos Int. 2001;12(1):24–7.
Circaannual rhythms and interactions of vitamin D metabolites, parathyroid hormone, and biochemical markers of skeletal homeostasis: a prospective study. J Bone Miner Res. 2000 Dec;15(12):2443–50.
Hypovitaminosis D in a sunny country: relation to lifestyle and bone markers. J Bone Miner Res. 2000 Sep;15(9):1856–62.
Disorders of bone metabolism in gastrointestinal and hepatic diseases. Ned Tijdschr Geneeskd. 2000 Mar 4;144(10):462–7. Review in Dutch.
Low vitamin D levels in outpatient postmenopausal women from a rheumatology clinic in Madrid, Spain: their relationship with bone mineral density. Osteoporos Int. 2000;11(9):739–44.
Vitamin D and vitamin D analogues for preventing fractures associated with involutional and post-menopausal osteoporosis. Cochrane Database Syst Rev. 2000;(2):CD000227. Review.
Vitamin D receptor displays DNA binding and transactivation as a heterodimer with the retinoid X receptor, but not with the thyroid hormone receptor. J Cell Biochem. 1999 Dec 1;75(3):462–80.
Vitamin D supplementation during infancy is associated with higher bone mineral mass in prepubertal girls. J Clin Endocrinol Metab. 1999 Dec;84(12):4541–4.
Vitamin D supplementation in postmenopausal black women. J Clin Endocrinol Metab. 1999 Nov;84(11):3988–90.
Treatment of glucocorticoid-induced osteoporosis with alfacalcidol/calcium versus vitamin D/calcium. Calcif Tissue Int. 1999 Oct;65(4):337–40.
Vitamin D therapy of osteoporosis: plain vitamin D therapy versus active vitamin D analog (D-hormone) therapy. Calcif Tissue Int. 1999 Oct;65(4):295–306. Review.
Resolution of vitamin D insufficiency in osteopenic patients results in rapid recovery of bone mineral density. J Clin Endocrinol Metab. 1999 Aug;84(8):2729–30.
Bone mineral density of the spine and femur in healthy Saudi females: relation to vitamin D status, pregnancy, and lactation. Calcif Tissue Int. 1999 Jul;65(1):23–8.
Early postmenopausal bone loss is prevented by estrogen and partially by 1alpha-OH-vitamin D3: therapeutic effects of estrogen and/or 1alpha-OH-vitamin D3. Calcif Tissue Int. 1999 Jul;65(1):16–22.
Vitamin D status, parathyroid function and femoral bone density in an elderly Swedish population living at home. Aging (Milano). 1999 Jun;11(3):200–7.
Effect of immobilization on vitamin D status and bone mass in chronically hospitalized disabled stroke patients. Age Ageing. 1999 May;28(3):265–9.
Occult vitamin D deficiency in postmenopausal US women with acute hip fracture. JAMA. 1999 Apr 28;281(16):1505–11.
Osteoporosis in adult patients with celiac disease. Bone. 1999 Mar;24(3):249–55.
Amelioration of osteopenia and hypovitaminosis D by 1alpha-hydroxyvitamin D3 in elderly patients with Parkinson's disease. J Neurol Neurosurg Psychiatry. 1999 Jan;66(1):64–8.
High prevalence of hypovitaminosis D among free-living postmenopausal women referred to an osteoporosis outpatient clinic in northern Italy for initial screening. Osteoporos Int. 1999;9(3):226–9.
High prevalence of vitamin D deficiency and reduced bone mass in elderly women with Alzheimer's disease. Bone. 1998 Dec;23(6):555–7.
Measurement of vitamin D3 metabolites in smelter workers exposed to lead and cadmium. Occup Environ Med. 1998 Jul;55(7):446–52.
The roles of calcium and vitamin D in the prevention of osteoporosis. Endocrinol Metab Clin North Am. 1998 Jun;27(2):389–98. Review.
Seasonal deficiency of vitamin D in children: a potential target for osteoporosis-preventing strategies? J Bone Miner Res. 1998 Apr;13(4):544–8.
Vitamin D and bone mineral density. Osteoporos Int. 1998;8(2):110–4.
High prevalence of vitamin D deficiency and reduced bone mass in Parkinson's disease. Neurology. 1997 Nov;49(5):1273–8.
Comparison of the long-term effects of oral estriol with the effects of conjugated estrogen, 1-alpha-hydroxyvitamin D3 and calcium lactate on vertebral bone loss in early menopausal women. Maturitas. 1997 Sep;28(1):11–7.
Effect of calcium and vitamin D supplementation on bone density in men and women 65 years of age or older. N Engl J Med. 1997 Sep 4;337(10):670–6.
Importance of albumin, 25(OH)-vitamin D and IGFBP-3 as risk factors in elderly women and men with hip fracture. Osteoporos Int. 1997;7(5):457–62.
Calcium and vitamin D3 supplementation prevents bone loss in the spine secondary to low-dose corticosteroids in patients with rheumatoid arthritis. A randomized, double-blind, placebo-controlled trial. Ann Intern Med. 1996 Dec 15;125(12):961–8.
Therapy of osteoporosis: calcium, vitamin D, and exercise. Am J Med Sci. 1996 Dec;312(6):278–86. Review.
Clinical practice guidelines for the diagnosis and management of osteoporosis. Scientific Advisory Board, Osteoporosis Society of Canada. CMAJ. 1996 Oct 15;155(8):1113–33.
Prevention and management of osteoporosis: consensus statements from the Scientific Advisory Board of the Osteoporosis Society of Canada. 8. Vitamin D metabolites and analogs in the treatment of osteoporosis. CMAJ. 1996 Oct 1;155(7):955–61. Review.
Prevention and management of osteoporosis: consensus statements from the Scientific Advisory Board of the Osteoporosis Society of Canada. 4. Calcium nutrition and osteoporosis. CMAJ. 1996 Oct 1;155(7):935–9. Review.
Antagonistic effects of transforming growth factor-beta on vitamin D3 enhancement of osteocalcin and osteopontin transcription: reduced interactions of vitamin D receptor/retinoid X receptor complexes with vitamin E response elements. Endocrinology. 1996 May;137(5):2001–11.
Vitamin D and bone health. J Nutr. 1996 Apr;126(4 Suppl):1159S–64S.
Lower serum 25-hydroxyvitamin D is associated with increased bone resorption markers and lower bone density at the proximal femur in normal females: a population-based study. Exp Clin Endocrinol Diabetes. 1996;104(3):289–92.
Vitamin D deficiency in veterans with chronic spinal cord injury. Metabolism. 1995 Dec;44(12):1612–6.
Bone density, vitamin D nutrition, and parathyroid hormone levels in women with dementia. J Am Geriatr Soc. 1995 Oct;43(10):1088–91.
Vitamin D receptor gene polymorphism, bone mass, body size, and vitamin D receptor density. Calcif Tissue Int. 1995 Aug;57(2):161–2.
Rates of bone loss in postmenopausal women randomly assigned to one of two dosages of vitamin D. Am J Clin Nutr. 1995 May;61(5):1140–5.
Environmental factors that influence the cutaneous production of vitamin D. Am J Clin Nutr. 1995 Mar;61(3 Suppl):638S–645S. Review.
Single-dose cholecalciferol suppresses the winter increase in parathyroid hormone concentrations in healthy older men and women: a randomized trial. Am J Clin Nutr. 1994 May;59(5):1040–4.
Vitamin D adequacy: a possible relationship to breast cancer. Adv Exp Med Biol. 1994;364:109–14. Review.
Low serum vitamin D metabolites in women with rheumatoid arthritis. Scand J Rheumatol. 1993;22(4):172–7.
Vitamin D3 and calcium to prevent hip fractures in the elderly women. N Engl J Med. 1992 Dec 3;327(23):1637–42.
Preventing wintertime bone loss: effects of vitamin D supplementation in healthy postmenopausal women. Nutr Rev. 1992 Feb;50(2):52–4. Review.
Effect of vitamin D supplementation on wintertime and overall bone loss in healthy postmenopausal women. Ann Intern Med. 1991 Oct 1;115(7):505–12.
Subclinical vitamin D deficiency in postmenopausal women with low vertebral bone mass. J Clin Endocrinol Metab. 1991 Mar;72(3):628–34.
Is there a role for vitamin D in osteoporosis? Calcif Tissue Int. 1991;49 Suppl:S46–9. Review.
Oral manifestations of metabolic bone disease: vitamin D and osteoporosis. Compendium. 1990 Oct;11(10):612, 614–8. Review.
Bone mineral content, 25-hydroxycalciferol and zinc serum levels in insulin-dependent (type I) diabetic patients. Arch Invest Med (Mex). 1990 Apr–Jun;21(2):195–9.
Main endocrine modulators of vitamin D hydroxylases in human pathophysiology. J Steroid Biochem. 1987;27(4–6):815–24. Review.
The effect of vitamin D on bone in vivo. Endocrinology. 1986 Jun;118(6):2217–24.
Studies on the hydroxylation of vitamin D in man. Ann Med Interne (Paris). 1986;137(3):206–8.
Vitamin D metabolism and chronic liver disease. Ann Clin Lab Sci. 1984 May–Jun;14(3):189–97. Review.
Bone response to phosphate and vitamin D metabolites in the hypophosphatemic male mouse. Calcif Tissue Int. 1982 Mar;34(2):158–64.
Vitamin D metabolites and bone mineralization in man. J Clin Endocrinol Metab. 1978 Feb;46(2):284–94.
Osteoporosis and osteomalacia. Schweiz Med Wochenschr. 1975 Apr 12;105(15):466–70.

back to research menu

*These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease.

Unless otherwise expressly stated, all site content licensed under a Creative Commons License.